Search

There is a growing need to harness miRNA biology to develop new technologies and focus on its translational applications

The New Delhi Declaration’s policy commitments in the health sector emphasise the role of the G20 in revising the existing financial and global heal

Policies and tailored interventions need to be adopted to mitigate the growing global threat of antimicrobial resistance

India must redouble its efforts in the WTO to have the TRIPS waiver extended to cover therapeutics and diagnostics and use its G20 Presidency and the

The arrival of vaccines against Covid-19 gives hope in ending the pandemic that has claimed close to 2.84 million lives so far. However, inoculating millions of people all over the world would require the massive production of vaccines, followed by their equitable distribution. An impediment to production and distribution of vaccines is the intellectual property (IP) rights that their developers enjoy. India and South Africa have together propo

Globally, healthcare has made great strides in making vaccines, diagnostics and therapeutics available to more people. Yet, infectious diseases continue to pose a significant threat in many parts of the world, and the SARS, Ebola, and Zika crises are only a few of the recent outbreaks that draw attention to the weaknesses of public health systems. In India, the recent epidemics of Nipah virus and acute encephalitis syndrome call attention to the

In an effort to facilitate the digitisation of the country’s healthcare systems, India released a National Digital Health Blueprint in January 2020, which provides a detailed framework for a “Federated National Health Information System.” This brief makes a case for expanding the scope of the blueprint to include digital therapeutics, digital diagnostics, and telemedicine. It proposes a “National Digital Health Blueprint 2.0,” with dive